Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01603095 · ClinicalTrials.gov registry record
A Multicenter, Multinational Clinical Assessment Study for Pediatric Patients With Achondroplasia
A clinical trial of Achondroplasia, sponsored by BioMarin Pharmaceutical.
- Completed
- Registry status
- 363
- Enrollment target
- 20
- Study locations
NCT01603095 is a study of Achondroplasia that has completed, run by BioMarin Pharmaceutical. The registered enrollment target is 363 participants, above the 111-participant average among 9 other Achondroplasia trials with a reported enrollment target (227% higher). The trial reports 20 study locations across 10 states.
The verdict
NCT01603095, a study of Achondroplasia, has completed, sponsored by BioMarin Pharmaceutical.
- COMPLETED
- Registry status
- 363 participants
- Enrollment target
- 20
- Study locations
Study Summary
Multicenter, multinational study to collect consistent baseline growth measurements on pediatric patients with Achondroplasia being considered for subsequent enrollment in future studies sponsored by BioMarin. No study drug is administered.
Conditions Studied
Study Locations (20)
Other
- The Children's Hospital at Westmead - Westmead
- Osaka University Hospital - Osaka
- Saitama Children's Medical Center - Saitama
- Tokushima University Hospital - Tokushima
- Institut Catala de Traumatologica I Medicina de l'Esport - Barcelona
- Hospital Sant Joan de Deu Barcelona - Barcelona
- Hospital Universitario Virgen de la Victoria - Málaga
- Acibadem University School of Medicine - Istanbul
- Guy's and St. Thomas NHS Foundation Trust Evelina Children's Hospital - London
- Sheffield Children's NHS Foundation Trust - Sheffield
California
- Harbor-UCLA Medical Center - Los Angeles
- Children's Hospital and Research Center Oakland - Oakland
Delaware
- Nemours/Alfred I. duPont Hospital for Children - Wilmington
Georgia
- Emory University - Decatur
Illinois
- Ann and Robert H Lurie Children's Hospital of Chicago - Chicago
Ohio
- Cincinnati Children's Hospital Medical Center - Cincinnati
Tennessee
- Vanderbilt University - Nashville
Texas
- Baylor College of Medicine - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 363 participants |
| Start Date | 2012-04 |
| Est. Completion | 2021-02 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01603095
The ClinicalTrials.gov registry entry for NCT01603095 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 363 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 111-participant average among 9 other Achondroplasia trials with a reported enrollment target (227% higher). The listed sponsor is BioMarin Pharmaceutical, which has 80 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Achondroplasia appearing as the primary indexed condition, and to 0 interventions.
NCT01603095 reports 20 study locations spanning 10 distinct geographic areas - top geographies include Other, California, Delaware.
Frequently Asked Questions
What is clinical trial NCT01603095 about?
NCT01603095 is a clinical study titled "A Multicenter, Multinational Clinical Assessment Study for Pediatric Patients With Achondroplasia". Multicenter, multinational study to collect consistent baseline growth measurements on pediatric patients with Achondroplasia being considered for subsequent enrollment in future studies sponsored by BioMarin. No study drug is administered.
What is the current status of trial NCT01603095?
This trial is currently completed. The enrollment target is 363 participants. The study started on 2012-04. Estimated completion is 2021-02.
What conditions does trial NCT01603095 study?
This clinical trial studies the following conditions: Achondroplasia.
Who is sponsoring clinical trial NCT01603095?
This trial is sponsored by BioMarin Pharmaceutical, which has 80 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01603095 being conducted?
This trial has 20 study locations across California, Delaware, Georgia, Illinois, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Achondroplasia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Interventional Study of Infigratinib in Children < 3 Years Old With Achondroplasia (ACH)
RECRUITING · Phase 2
-
A Study of TYRA-300 in Children With Achondroplasia: BEACH301
RECRUITING · Phase 2
-
VIrtual STudy in Achondroplasia for the US (VISTA)
RECRUITING
-
A Clinical Trial to Evaluate Efficacy and Safety of TransCon CNP Compared With Placebo in Infants (0 to <2 Years of Age) With Achondroplasia
RECRUITING · Phase 2
-
An Extension Study to Evaluate Safety and Efficacy of BMN 111 in Children With Achondroplasia
ACTIVE NOT RECRUITING · Phase 2
-
A Study to Evaluate Long-Term Safety, Tolerability, & Efficacy of BMN 111 in Children With Achondroplasia (ACH)
ACTIVE NOT RECRUITING · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.